Securities Fraud Class Action Filed Against RxSight, Inc. (RXST) – Legal Firm Reminds …

Investors have been reminded of the upcoming deadline to participate in a securities fraud class action against RxSight, Inc. (RXST). The deadline for investors to be included in the class action is September 22, 2025, according to Levi & Korsinsky.

The class action lawsuit was filed against RxSight, Inc. for alleged violations of federal securities laws. The lawsuit claims that the company made false and misleading statements regarding its business, operations, and prospects. As a result, investors suffered losses when the truth about RxSight’s financial health and business practices was revealed.

Investors who purchased shares of RxSight, Inc. stock between February 27, 2020, and August 9, 2021, may be eligible to participate in the class action lawsuit. The lawsuit alleges that RxSight, Inc. failed to disclose important information to investors, including issues with its Light Adjustable Lens product, which had a lower selling volume than the company had indicated.

Furthermore, the lawsuit claims that RxSight, Inc. did not have adequate internal controls to prevent misleading statements from being made. When the truth about the company’s business practices and financial health came to light, investors suffered significant financial losses.

Investors who wish to participate in the securities fraud class action against RxSight, Inc. are encouraged to contact Levi & Korsinsky before the September 22, 2025 deadline. By participating in the class action, investors may be able to recover some of their losses resulting from the alleged securities fraud committed by RxSight, Inc.

It is essential for investors to be aware of their rights and options when they have suffered financial losses due to securities fraud. By participating in a class action lawsuit, investors can hold companies accountable for their misleading statements and potentially recover some of the losses they have incurred.

Investors who believe they may have a claim against RxSight, Inc. for securities fraud should not hesitate to contact Levi & Korsinsky before the September 22, 2025 deadline. Time is of the essence, and investors must act promptly to protect their rights and seek potential compensation for the losses they have suffered.